Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…

Genetic Testing in Breast Cancer: Innovations in Diagnosis and Treatment explores the pressing demands in breast cancer care for advanced, less invasive diagnostic tools that facilitate early detection and effective monitoring of therapeutic progress. With a particular emphasis on triple-negative breast cancer (TNBC), the book presents a thorough examination of the latest advancements in genetic testing, such as next-generation sequencing and the Sanger method. By analyzing these technologies, the volume demonstrates how they are fundamentally transforming both the early diagnosis process and the customization of treatment plans for individuals affected by breast cancer.
The book provides practical case studies, encompassing other breast cancer subtypes, including HER2-positive cases. It addresses the integration of genetic testing into clinical practice, discusses hereditary mutations, and underscores the importance of genetic counseling. The editors also highlight ongoing challenges and emerging opportunities in the field, ensuring that students, researchers, oncologists, pharmacologists, and healthcare professionals gain a comprehensive understanding.
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
Stock availability can be subject to change without notice. We recommend calling the shop or contacting our online team to check availability of low stock items. Please see our Shopping Online page for more details.
Genetic Testing in Breast Cancer: Innovations in Diagnosis and Treatment explores the pressing demands in breast cancer care for advanced, less invasive diagnostic tools that facilitate early detection and effective monitoring of therapeutic progress. With a particular emphasis on triple-negative breast cancer (TNBC), the book presents a thorough examination of the latest advancements in genetic testing, such as next-generation sequencing and the Sanger method. By analyzing these technologies, the volume demonstrates how they are fundamentally transforming both the early diagnosis process and the customization of treatment plans for individuals affected by breast cancer.
The book provides practical case studies, encompassing other breast cancer subtypes, including HER2-positive cases. It addresses the integration of genetic testing into clinical practice, discusses hereditary mutations, and underscores the importance of genetic counseling. The editors also highlight ongoing challenges and emerging opportunities in the field, ensuring that students, researchers, oncologists, pharmacologists, and healthcare professionals gain a comprehensive understanding.